KR940011435A - N,n-이치환된 아릴사이클로알킬아민, 이의 염, 이들 화합물을 함유하는 약제학적 조성물 및 이의 용도 및 이의 제조방법 - Google Patents

N,n-이치환된 아릴사이클로알킬아민, 이의 염, 이들 화합물을 함유하는 약제학적 조성물 및 이의 용도 및 이의 제조방법 Download PDF

Info

Publication number
KR940011435A
KR940011435A KR1019930024711A KR930024711A KR940011435A KR 940011435 A KR940011435 A KR 940011435A KR 1019930024711 A KR1019930024711 A KR 1019930024711A KR 930024711 A KR930024711 A KR 930024711A KR 940011435 A KR940011435 A KR 940011435A
Authority
KR
South Korea
Prior art keywords
group
methyl
compound
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019930024711A
Other languages
English (en)
Korean (ko)
Inventor
마이어 롤란트
뮐러 페터
보이툰 에버하르트
후르나우스 루돌프
마르크 미카엘
아이젤레 베른하르트
부드진스키 랄프-미카엘
할러마이어 게르하르트
Original Assignee
디터 라우딘, 게르하르트 후버
닥터 칼 토메 게젤샤프트 미트 베슈랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디터 라우딘, 게르하르트 후버, 닥터 칼 토메 게젤샤프트 미트 베슈랭크터 하프퉁 filed Critical 디터 라우딘, 게르하르트 후버
Publication of KR940011435A publication Critical patent/KR940011435A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/79—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
KR1019930024711A 1992-11-20 1993-11-19 N,n-이치환된 아릴사이클로알킬아민, 이의 염, 이들 화합물을 함유하는 약제학적 조성물 및 이의 용도 및 이의 제조방법 Withdrawn KR940011435A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4239151.2 1992-11-20
DE4239151A DE4239151A1 (de) 1992-11-20 1992-11-20 N,N-Disubstituierte Arylcycloalkylamine, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
KR940011435A true KR940011435A (ko) 1994-06-21

Family

ID=6473324

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930024711A Withdrawn KR940011435A (ko) 1992-11-20 1993-11-19 N,n-이치환된 아릴사이클로알킬아민, 이의 염, 이들 화합물을 함유하는 약제학적 조성물 및 이의 용도 및 이의 제조방법

Country Status (19)

Country Link
US (1) US5455273A (https=)
EP (1) EP0599203A1 (https=)
JP (1) JPH06211763A (https=)
KR (1) KR940011435A (https=)
CN (1) CN1093082A (https=)
AU (1) AU665281B2 (https=)
CA (1) CA2103381A1 (https=)
CZ (1) CZ248593A3 (https=)
DE (1) DE4239151A1 (https=)
FI (1) FI935110L (https=)
HU (1) HU211996B (https=)
IL (1) IL107653A0 (https=)
MX (1) MX9307232A (https=)
NO (1) NO934196L (https=)
NZ (1) NZ250230A (https=)
PL (1) PL301101A1 (https=)
SK (1) SK123993A3 (https=)
TW (1) TW252097B (https=)
ZA (1) ZA938647B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10516835B2 (en) 2007-10-31 2019-12-24 Samsung Electronics Co., Ltd. Image apparatus and method for receiving video signal in multiple video modes

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4239150A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US5962507A (en) * 1994-04-25 1999-10-05 Dr. Karl Thomae Gmbh O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds, and their use, as well as a method of preparing them
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
EP0738510A3 (fr) * 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
EP1032377B1 (en) 1997-11-21 2010-11-17 Purdue Neuroscience Company Substituted 2-aminoacetamides and the use thereof
DE19754795A1 (de) * 1997-12-10 1999-06-17 Boehringer Ingelheim Pharma Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US6410521B1 (en) * 1998-06-12 2002-06-25 Osteoscreen, Inc. Nutritional supplements for stimulating bone growth
AU2001263130A1 (en) 2000-06-06 2001-12-17 Warner Lambert Company Bicyclic cyclohexylamines and their use as nmda receptor antagonists
CZ2003451A3 (cs) * 2000-08-16 2003-10-15 F. Hoffmann-La Roche Ag Nové deriváty aminocyklohexanu
IL162104A0 (en) * 2001-12-12 2005-11-20 Hoffmann La Roche Substituted cyclohexane derivatives
US7012077B2 (en) 2001-12-20 2006-03-14 Hoffmann-La Roche Inc. Substituted cyclohexane derivatives
AU2003299034A1 (en) * 2002-09-20 2004-04-08 Griscom Bettle Iii Transdermal compositions
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
JP5453165B2 (ja) * 2010-05-13 2014-03-26 信越化学工業株式会社 アルデヒド及びケトンの製造方法
RU2016149812A (ru) 2014-06-06 2018-07-17 Флексус Байосайенсиз, Инк. Иммунорегулирующие средства
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
UY36391A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
BR112017008809A2 (pt) 2014-11-05 2017-12-19 Flexus Biosciences Inc agentes imunorreguladores
KR20190004743A (ko) * 2016-05-04 2019-01-14 브리스톨-마이어스 스큅 컴퍼니 인돌아민 2,3-디옥시게나제의 억제제 및 그의 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979444A (en) * 1974-05-28 1976-09-07 The Upjohn Company 4-Arylcyclohexylamines
US4886929A (en) * 1987-06-15 1989-12-12 Uop Inc. Separation of para-xylene
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10516835B2 (en) 2007-10-31 2019-12-24 Samsung Electronics Co., Ltd. Image apparatus and method for receiving video signal in multiple video modes

Also Published As

Publication number Publication date
ZA938647B (en) 1995-05-19
SK123993A3 (en) 1994-09-07
FI935110A0 (fi) 1993-11-18
PL301101A1 (en) 1994-06-27
JPH06211763A (ja) 1994-08-02
HU211996B (en) 1996-01-29
AU5182593A (en) 1994-06-02
FI935110A7 (fi) 1994-05-21
NO934196L (no) 1994-05-24
TW252097B (https=) 1995-07-21
IL107653A0 (en) 1994-02-27
NZ250230A (en) 1996-02-27
FI935110L (fi) 1994-05-21
HU9303298D0 (en) 1994-03-28
CZ248593A3 (en) 1994-06-15
NO934196D0 (no) 1993-11-19
CA2103381A1 (en) 1994-05-21
DE4239151A1 (de) 1994-05-26
EP0599203A1 (de) 1994-06-01
HUT65760A (en) 1994-07-28
MX9307232A (es) 1994-07-29
AU665281B2 (en) 1995-12-21
CN1093082A (zh) 1994-10-05
US5455273A (en) 1995-10-03

Similar Documents

Publication Publication Date Title
KR940011435A (ko) N,n-이치환된 아릴사이클로알킬아민, 이의 염, 이들 화합물을 함유하는 약제학적 조성물 및 이의 용도 및 이의 제조방법
EP0975644B1 (en) Substituted metallocene compounds for olefin polymerization catalyst systems, their intermediates and methods for preparing them
KR100257619B1 (en) Azole compounds, their production and use
FI914163A0 (fi) Heterocykliska derivat.
EP1063228A4 (en) CYCLOALCENE DERIVATIVES, THEIR MANUFACTURING METHOD AND THE USE THEREOF
BR9608128A (pt) Ferrocenos di-halogenados e processo para sua preparação
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
WO2021046523A8 (en) Composition of matter for use in organic light-emitting diodes
HRP20030566B1 (en) Improved process for carbapenem synthesis
EP1535922A4 (en) PYRROLOPYRIDINE DERIVATIVE AND ITS USE
UA86013C2 (ru) Производные арилалкилкарбаматов, их получение и применение в лечении
CO4410329A1 (es) Nuevos pirrolocarbazoles
EP1279665A3 (en) A process for the preparation of perindopril, its analogous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds
EP2088142A3 (en) Dihydropyrimidines, process for their preparation and use thereof.
WO2005058812A3 (en) Prostaglandin synthesis
KR960701031A (ko) N-(베타-분지된 알킬)-1,2-벤즈이소티아졸린-3-온, 이의 제조 및 이의 공업 살충제로서의 용도(N-(beta-branched alkyl)-1,2-benzisothiazolin-3-ones, their preparation and use as industrial biocides)
EP0604355A3 (en) Alkyl substituted heterocyclic compounds.
BR9101280A (pt) Composto soluvel em oleo lubrificante,processo para preparacao de composto soluvel em oleo,composto e compossicao de oleo lubrificante
AR038055A1 (es) Proceso para preparar 2- (fenilo sustituido) - 2 - hidroxi - etil carbamatos.
KR960700218A (ko) 트리페닐에틸렌 화합물의 z 이성체 산부가염의 제조방법(process for producing acid-addition salt of z-isomer of triphenylethylene compound)
KR950018011A (ko) 비스인돌릴말레이미드의 개선된 합성 방법
US5190723A (en) Process for inhibiting corrosion
CY1485A (en) Benzothienylallylamines process for their production and their use as pharmaceuticals
JP7142440B2 (ja) （ジアリールアミノ）カルバゾールの製造方法
MX2022008241A (es) Un método para preparar compuestos de cumarina sustituidos con amidoalquilo en la posición 3, los productos e intermedios relacionados con los mismos.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19931119

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid